Mr. Paul Duffy reports

AI/ML INNOVATIONS INC. CLOSES FINAL TRANCHE OF PRIVATE PLACEMENT

AI-ML Innovations Inc. has closed the second and final tranche of its previously announced non-brokered private placement. Pursuant to the second tranche of the offering, the company has issued an aggregate of 7.3 million units at a price of five cents per unit to raise aggregate gross proceeds of $365,000. Each unit comprises one common share of the company and one common share purchase warrant. Subject to the anti-dilution provisions that are contained in the certificates governing the terms of the warrants, each whole warrant is exercisable to acquire one common share at a price of 15 cents for a period of 60 months from the date of issuance of the warrants.

In connection with the second tranche of the offering, the company also issued an aggregate of 196,000 broker warrants to eligible finders assisting in the offering, with each broker warrant entitling the holder to acquire one common share at an exercise price of 15 cents for a period of five years.

All securities issued and issuable in connection with the second tranche of the offering are subject to a statutory hold period expiring on Jan. 15, 2027.

About AI-ML Innovations Inc.

AI-ML Innovations is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. The company's proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights -- supporting earlier diagnosis, personalized treatment and more effective care. AI-ML's shares trade on the Canadian Securities Exchange (symbol AIML), the OTCQB Venture Market (symbol AIMLF) and the Frankfurt Stock Exchange (symbol 42FB).

We seek Safe Harbor.